Glucose Health, Inc. SEC filings GLUC
Glucose Health, Inc. has 140 filings in SEC EDGAR's recent list, going back to Dec 7, 2007. Its latest annual report, Form 10-K, was filed on Mar 29, 2017 for the period ended Dec 31, 2016. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2017, covering the quarter ended Sep 30, 2017. The most recent current report (Form 8-K) was filed on Apr 11, 2017 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | May 8, 2015 | May 8, 2015 |
Showing 1 filing. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- GLUC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bentonville, AR
- SEC filer status
- Smaller reporting company
- SEC CIK
- 1420108
- Former names
- Bio-Solutions Corp. (until Dec 16, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.